Two vaccine projects among winners of EU's first COVID-19 research call

The European Commission’s first COVID-19 research call includes two vaccine development projects among the 17 projects that received support. One vaccine project, called Opencorona, is led by researchers at the Karolinska Institutet, Sweden’s top medical university, who hope to begin phase one human clinical trials in 2021.

The other, Prevent-nCoV, is led by AdaptVac, a Danish biotech start-up. AdaptVac hopes to complete safety and efficacy testing in the next 12 months on its synthetic virus-like particle technology. 
 
News article - Science|Business